Press release
Angioedema Treatment Market Size, and Share - Global Industry Insights, Opportunity Analysis, 2018-2026
To get detailed table of content (ToC), please click: https://www.coherentmarketinsights.com/ongoing-insight/toc/1371
Frequent approval of novel drugs from regulatory bodies is expected to boost growth of global angioedema treatment market
In 2017, U.S. Food and Drug Administration approved Haegarda, a C1 Esterase Inhibitor (Human) for subcutaneous administration indicated for the preventing hereditary angioedema (HAE) in adult and adolescent patients. In 2014, Pharming Group NV and Salix Pharmaceuticals, Ltd. received US Food and Drug Administration (FDA) approval for RUCONEST (C1 Esterase Inhibitor [Recombinant]) 50 IU/kg, indicated for the treatment of acute angioedema attacks in adult and adolescent patients with HAE. In 2016, CSL Behring received FDA approval for Berinert [C1 Esterase Inhibitor (Human)], indicated for the treatment of HAE attacks in pediatric patients. These multiple approvals of new drugs by regulatory bodies are expected to drive growth of global angioedema treatment market over the forecast period. Furthermore, initiatives taken by various organizations to support treatment of angioedema is also expected to support the growth of global angioedema treatment market. For instance in 2015, British Society for Allergy and Clinical Immunology (BSACI) provided a guideline for the management of chronic urticaria and angioedema. In 2013, the World Allergy Organization (WAO) also provided guideline for the Management of Hereditary Angioedema.
Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/1371
Angioedema Treatment Market Taxonomy
The angioedema treatment market is segmented on the basis of condition type, drug type, route of administration, distribution channel, and geography
By Condition Type:
Allergic angioedema
Drug-induced angioedema
Idiopathic angioedema
Hereditary angioedema (HAE)
By Drug Type:
C1 esterase inhibitor
Cinryze
Berinert
Ruconest
Haegarda
Selective bradykinin B2 receptor antagonist
Firazyr
Kallikrein inhibitor
Kalbitor
Others
By Route of Administration:
Injection
Intravenous
Subcutaneous
Oral
By Distribution Channel
Hospitals
Retail pharmacies
Online pharmacies
Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/angioedema-treatment-market-1371
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit Blog: https://globalresearchtrends.blogspot.com/
Connect with us on LinkedIn @ https://www.linkedin.com/company/coherent-market-insights
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Angioedema Treatment Market Size, and Share - Global Industry Insights, Opportunity Analysis, 2018-2026 here
News-ID: 1110917 • Views: …
More Releases from Coherent Market Insights
Nephrology And Urology Devices Market to See Booming Growth 2024-2031 | Freseniu …
Coherent Market Insights introduces new research on the Nephrology And Urology Devices Market covering the micro level of analysis by competitors and key business segments (2024-2031). This report study encompasses a thorough examination of diverse segments, including opportunities, size, development, innovation, sales, and overall growth trajectory of major players. The research is carried out on primary and secondary statistical sources, providing a blend of qualitative and quantitative insights. The report…
RFID in Healthcare Market Dynamic Growth Factors, and Outlook until 2031 | Hitac …
Latest Report Published by Coherent Market Insights highlights the growth prospects of the Rfid In Healthcare Market from 2024 to 2031. In-depth research on Industry Size, Share, Business Analysis, Growth Factors, and Regional Forecast. This report covers a comprehensive investigation of the information that influences the market regarding fabricates, business providers, market players, and clients. The report provides data about the aspects which drive the expansion of the Rfid In…
Circular Dichroism (CD) Spectrometer Market Set to Witness Extraordinary Growth …
Latest Report Published by Coherent Market Insights highlights the growth prospects of the Circular Dichroism (CD) Spectrometer Market from 2024 to 2031. In-depth research on Industry Size, Share, Business Analysis, Growth Factors, and Regional Forecast. This report covers a comprehensive investigation of the information that influences the market regarding fabricates, business providers, market players, and clients. The report provides data about the aspects which drive the expansion of the Circular…
Chromatography Market Expected to Witness Strong Growth by 2031 | Thermo Fisher …
Latest Report Published by Coherent Market Insights highlights the growth prospects of the Chromatography Market from 2024 to 2031. In-depth research on Industry Size, Share, Business Analysis, Growth Factors, and Regional Forecast. This report covers a comprehensive investigation of the information that influences the market regarding fabricates, business providers, market players, and clients. The report provides data about the aspects which drive the expansion of the Chromatography industry. The research…
More Releases for Angioedema
Angioedema Treatment Market 2022 | Detailed Report
This report provides an informative view about the competitive aspect of the global market. It includes detailed picture of the exhibition of a portion of the essential global players working in the Angioedema Treatment market. The research study also provides historical record with profits predictions and forecasts from 2022 to 2028. Also, the business manufacturing of the notable manufacturers is also emphasized with technical data in the report.
This report is…
Hereditary Angioedema Therapeutics Market - Forecast to 2026
As per the research conducted by GME, the Global Hereditary Angioedema Therapeutics Market will grow with a CAGR value of 8.2%. Population growth, as well as lifestyle changes, improved insurance programs, and increased efforts by pharmaceutical and biotechnology companies to develop new products and solutions for the industry, are expected to fuel market revenue for Hereditary Angioedema in the years ahead.
Browse 153 Market Data Tables and 113 Figures spread through…
Hereditary Angioedema Market Global Comprehensive Research 2020
Global Hereditary Angioedema Market research report published by market insight reports explores the current outlook in global and key regions from the perspective of Major Players, Countries, Product types and end industries. This report analyzes top players in the global market, and divides the Market into several parameters.
This Hereditary Angioedema Market research report identifies the competitive landscape of industries to understand the competition at International level. This report study describes…
Angioedema Market: Rampant Allergies to Bolster Angioedema Treatment
Angioedema, an edema of spots beneath the skin or mucosa aggravating throat, face, limbs and genitals has taken the lives of more than five thousand people between 1979 and 2010. Unlike urticarial that attacks merely the upper dermis, angioedema strikes the deeper layers, including the dermis, the mucosa, submucosal tissues and the subcutaneous tissue. These assimilations are according to the report titled “Angioedema Market,” which has been recently added to…
Angioedema Market: Rampant Allergies to Bolster Angioedema Treatment
Angioedema, an edema of spots beneath the skin or mucosa aggravating throat, face, limbs and genitals has taken the lives of more than five thousand people between 1979 and 2010. Unlike urticarial that attacks merely the upper dermis, angioedema strikes the deeper layers, including the dermis, the mucosa, submucosal tissues and the subcutaneous tissue. These assimilations are according to the report titled “Angioedema Market,” which has been recently added to…
Hereditary Angioedema Market is propelled by rise in hereditary angioedema (HAE) …
Some of the prominent names operating in the global hereditary angioedema market are Pharming Group NV, Shire plc, CSL Limited, Ionis Pharmaceuticals, Inc., iBio Inc., and BioCryst Pharmaceuticals, Inc.
As per a report by Transparency Market Research, the global hereditary angioedema market will likely rise at a healthy 9.1% CAGR between 2017 and 2025 to become worth US$3.81 bn by 2025 from US$ 1.73 bn in 2016.
Read Report Overview: https://www.transparencymarketresearch.com/hereditary-angioedema-market.html
Superior Healthcare…
